FindTrial
Sign In

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-002224-32-FR
Enrollment
Unknown
Registered
2012-09-04
Start date
2013-05-23
Completion date
Unknown
Last updated
2013-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Afinitor Product Name: Evérolimus Pharmaceutical Form: Tablet CAS Number: 159351-69-6 Other descriptive name: EVEROLIMUS Concentration unit: mg milligram(s) Concentration type: equal Conce

Sponsors

Fédération Francophone de Cancérologie Digestive
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 52 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20 ;Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 52 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 20

Exclusion criteria

Exclusion criteria: ;Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s): ;Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

France

Contacts

Public ContactChef de projet Marie MOREAU;Chef de projet Marie MOREAU ;

Fédération Francophone de Cancérologie Digestive;Fédération Francophone de Cancérologie Digestive

marie.moreau@u-bourgogne.fr;marie.moreau@u-bourgogne.fr+33380 39 34 04;+33380 39 34 04

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026